MedPath

Comparison of Apnea Tolerance in Two Positions of Patients With BMI 30-40

Not Applicable
Completed
Conditions
General Surgery
Registration Number
NCT03056820
Lead Sponsor
University of Kansas Medical Center
Brief Summary

The purpose of this study is to compare the effect of the 25° head-up position versus the 55° head-up position on tolerable apnea time (TAT) after induction of general anesthesia in patients with a body mass index (BMI) of 30-40.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
74
Inclusion Criteria
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Body Mass Index (BMI) of 30-40
  • Scheduled for an elective surgery that requires tracheal intubation
Exclusion Criteria
  • Patients with abnormalities of the upper airway that require awake tracheal intubation
  • Asthma
  • Chronic obstructive pulmonary disease
  • Congestive heart failure
  • Pregnant patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Tolerable Apnea Time (TAT)Time between start of induction of general anesthesia (SpO2 100%) to decline of SpO2 94%, up to eight minutes

Measure of the TAT between groups to determine if the TAT is a function of the participant's position.

Secondary Outcome Measures
NameTimeMethod
Length of time to intubation (TTI)Time between start of the tracheal intubation procedure to completion of tracheal intubation, up to 2 minutes
Peripheral arterial hemoglobin oxygen saturation (SpO2) troughTime until SpO2 decreased to 92%, up to 8 minutes

Measure of the rebound SpO2. It is the lowest SpO2 reading reached subsequent to start of mechanical ventilation at the SpO2 value of 94% and it represents final completion of SpO2 decline.

Trial Locations

Locations (1)

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

University of Kansas Medical Center
🇺🇸Kansas City, Kansas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.